4//SEC Filing
Gulino Richard L. 4
Accession 0001209191-18-015878
CIK 0001347178other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 5:33 PM ET
Size
10.2 KB
Accession
0001209191-18-015878
Insider Transaction Report
Form 4
Gulino Richard L.
SVP & General Counsel
Transactions
- Sale
Common Stock
2018-03-01$18.71/sh−3,660$68,473→ 115,073 total - Award
Common Stock
2018-02-28+30,000→ 118,733 total - Award
Employee Stock Option (Right to Buy)
2018-02-28+70,000→ 70,000 totalExercise: $18.85Exp: 2028-02-27→ Common Stock (70,000 underlying)
Footnotes (4)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments beginning February 28, 2019, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
- [F2]Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs as reflected in this Form 4. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.
- [F3]The price reported in Column 4 is a weighted average price. The Reporting The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.35 to $18.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
- [F4]The option vests in forty-eight (48) equal monthly installments beginning on February 28, 2018, provided the Reporting Person remains continuously employed by the Issuer through each vesting date.
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeother
Related Parties
1- filerCIK 0001652208
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 5:33 PM ET
- Size
- 10.2 KB